首页> 外国专利> Intracrine c-Kit Signaling as a Novel Therapeutic Target of Brain Tumors

Intracrine c-Kit Signaling as a Novel Therapeutic Target of Brain Tumors

机译:内分泌c-Kit信号作为脑肿瘤的新型治疗靶点

摘要

PURPOSE: A method for screening agents for preventing or treating brain tumor is provided to immediately apply as a therapeutic agent for brain tumor and to ensure safety. CONSTITUTION: A method for screening agents for preventing or treating brain tumor comprises: a step of contacting a test material to cells containing c-kit gene; a step of measuring c-kit expression level or c-kit phosphorylation; and a step of selecting the test material which causes down-regulation of c-kit expression or phosphorylation. A method for analyzing responsiveness of tumor patient by a material for preventing or treating tumor comprises: a step of contacting the material to cells containing c-kit gene from the patient; a step of measuring c-kit phosphorylation; and a step of determining responsiveness in case of down-regulation of the c-kit phosphorylation.
机译:目的:提供一种用于预防或治疗脑肿瘤的药物筛选方法,以立即用作脑肿瘤的治疗药物并确保安全。构成:一种用于预防或治疗脑瘤的药物的筛选方法,包括:使测试物质与含有c-kit基因的细胞接触的步骤;测量c-kit表达水平或c-kit磷酸化的步骤;选择导致c-kit表达或磷酸化下调的测试材料的步骤。一种通过用于预防或治疗肿瘤的材料来分析肿瘤患者的反应性的方法,包括:使该材料与来自患者的含有c-kit基因的细胞接触的步骤;测量c-kit磷酸化的步骤;以及在c-kit磷酸化下调的情况下确定响应性的步骤。

著录项

  • 公开/公告号KR101102044B1

    专利类型

  • 公开/公告日2012-01-04

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20090010615

  • 发明设计人 이태희;이지연;

    申请日2009-02-10

  • 分类号G01N33/574;G01N33/15;C12Q1/68;

  • 国家 KR

  • 入库时间 2022-08-21 17:08:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号